OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis
Changjun Wang, Yan Lin, Hanjiang Zhu, et al.
Breast Cancer (2021) Vol. 29, Iss. 2, pp. 314-323
Closed Access | Times Cited: 13
Changjun Wang, Yan Lin, Hanjiang Zhu, et al.
Breast Cancer (2021) Vol. 29, Iss. 2, pp. 314-323
Closed Access | Times Cited: 13
Showing 13 citing articles:
An overview of the research progress of BRCA gene mutations in breast cancer
Andi Wan, Guozhi Zhang, Dandan Ma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188907-188907
Closed Access | Times Cited: 12
Andi Wan, Guozhi Zhang, Dandan Ma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 4, pp. 188907-188907
Closed Access | Times Cited: 12
Pathologic complete response after neoadjuvant systemic therapy for breast cancer in BRCA mutation carriers and noncarriers
Sara P. Myers, Varadan Sevilimedu, Andrea V. Barrio, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
Sara P. Myers, Varadan Sevilimedu, Andrea V. Barrio, et al.
npj Breast Cancer (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 4
The impact of loco-regional treatment on ipsilateral breast cancer recurrence and outcomes in carriers of BRCA1/2 pathogenic variants
Rinat Bernstein‐Molho, Ory Haisraely, Shira Galper, et al.
Breast Cancer Research and Treatment (2025)
Open Access
Rinat Bernstein‐Molho, Ory Haisraely, Shira Galper, et al.
Breast Cancer Research and Treatment (2025)
Open Access
Surgical management of BRCA-mutation carriers: A single institution experience
Damiano Gentile, Agnese Losurdo, Andrea Sagona, et al.
European Journal of Surgical Oncology (2022) Vol. 48, Iss. 8, pp. 1706-1712
Closed Access | Times Cited: 16
Damiano Gentile, Agnese Losurdo, Andrea Sagona, et al.
European Journal of Surgical Oncology (2022) Vol. 48, Iss. 8, pp. 1706-1712
Closed Access | Times Cited: 16
Surgical Management of Inherited Breast Cancer: Role of Breast-Conserving Surgery
Francesca Magnoni, Virgilio Sacchini, Paolo Veronesi, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3245-3245
Open Access | Times Cited: 9
Francesca Magnoni, Virgilio Sacchini, Paolo Veronesi, et al.
Cancers (2022) Vol. 14, Iss. 13, pp. 3245-3245
Open Access | Times Cited: 9
Mutations and expressions of breast cancer 1/2 in lung cancer
Bokang Yan, Bin Xie, Meiyuan Huang, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 18, pp. 1753-1763
Open Access | Times Cited: 5
Bokang Yan, Bin Xie, Meiyuan Huang, et al.
Thoracic Cancer (2023) Vol. 14, Iss. 18, pp. 1753-1763
Open Access | Times Cited: 5
Risk‐reducing mastectomy decisions among women with mutations in high‐ and moderate‐ penetrance breast cancer susceptibility genes
Jacob G. Comeaux, Julie O. Culver, John Lee, et al.
Molecular Genetics & Genomic Medicine (2022) Vol. 10, Iss. 10
Open Access | Times Cited: 8
Jacob G. Comeaux, Julie O. Culver, John Lee, et al.
Molecular Genetics & Genomic Medicine (2022) Vol. 10, Iss. 10
Open Access | Times Cited: 8
Management and Clinical Outcomes of Breast Cancer in Women Diagnosed with Hereditary Cancer Syndromes in a Clinic-Based Sample from Colombia
María Carolina Sanabria‐Salas, Ana María Pedroza-Durán, Sandra Díaz, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2020-2020
Open Access | Times Cited: 1
María Carolina Sanabria‐Salas, Ana María Pedroza-Durán, Sandra Díaz, et al.
Cancers (2024) Vol. 16, Iss. 11, pp. 2020-2020
Open Access | Times Cited: 1
Management of breast cancer patients with BRCA gene mutations in Jordan: perspectives and challenges
Hikmat Abdel‐Razeq, Salah Abbasi, Ghadeer Abdeen, et al.
Hospital Practice (2023) Vol. 51, Iss. 4, pp. 184-191
Open Access | Times Cited: 2
Hikmat Abdel‐Razeq, Salah Abbasi, Ghadeer Abdeen, et al.
Hospital Practice (2023) Vol. 51, Iss. 4, pp. 184-191
Open Access | Times Cited: 2
Effect of low temperature plasma on the transcriptome of breast cancer cells
Lei Liu, Zhuna Yan, Fang Liu, et al.
Research Square (Research Square) (2024)
Open Access
Lei Liu, Zhuna Yan, Fang Liu, et al.
Research Square (Research Square) (2024)
Open Access
Is Breast Conserving Surgery Efficacious in Breast Cancer Patients with BRCA1 or BRCA2 Germline Mutation?
Selman Emiroğlu, Enver Özkurt, Neslihan Cabıoğlu, et al.
Breast Cancer Targets and Therapy (2023) Vol. Volume 15, pp. 163-173
Open Access | Times Cited: 1
Selman Emiroğlu, Enver Özkurt, Neslihan Cabıoğlu, et al.
Breast Cancer Targets and Therapy (2023) Vol. Volume 15, pp. 163-173
Open Access | Times Cited: 1
Prophylactic Risk‐Reducing Mastectomy (PRRM): A Set Practice or Catch‐22 Situation in LMIC. A Single‐Centre Prospective Cohort Study
Mehwish Mooghal, Lubna Mushtaque Vohra, Wajiha Khan, et al.
World Journal of Surgery (2023) Vol. 47, Iss. 9, pp. 2154-2160
Closed Access | Times Cited: 1
Mehwish Mooghal, Lubna Mushtaque Vohra, Wajiha Khan, et al.
World Journal of Surgery (2023) Vol. 47, Iss. 9, pp. 2154-2160
Closed Access | Times Cited: 1
Contralateral breast cancer risk with radiation therapy in BRCA mutation carriers: what do we tell patients?
Minna K. Lee, Mark E. Robson
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 11, pp. 1243-1245
Open Access
Minna K. Lee, Mark E. Robson
JNCI Journal of the National Cancer Institute (2023) Vol. 115, Iss. 11, pp. 1243-1245
Open Access
